样式: 排序: IF: - GO 导出 标记为已读
-
-
The Dangerous Precedent of Censoring Scientific Dissemination. Am. J. Transplant. (IF 8.9) Pub Date : 2024-09-06 Jesse D Schold,Timothy L Pruett,Elizabeth A Pomfret,Ty Dunn
The American Transplant Congress (ATC) is the largest national transplant meeting in the United States jointly sponsored by the American Society of Transplantation and the American Society of Transplant Surgeons. The 2024 ATC was held in Philadelphia, Pennsylvania during which a number of peer-reviewed scientific abstracts were censored from the program by the Health Resources and Services Administration
-
Perioperative extracorporeal membrane oxygenation in liver transplantation—bridge to transplantation, intraoperative salvage, and postoperative support: outcomes and predictors for survival in a large-volume liver transplant center Am. J. Transplant. (IF 8.9) Pub Date : 2024-09-05 Sameer Patel, Clemens Gutmann, Robert Loveridge, Tasneem Pirani, Chris Willars, Andre Vercueil, Milena Angelova-Chee, Varuna Aluvihare, Michael Heneghan, Krishna Menon, Nigel Heaton, William Bernal, Mark McPhail, Elton Gelandt, Lisa Morgan, Michael Whitehorne, Julia Wendon, Georg Auzinger
Data on perioperative extracorporeal membrane oxygenation (ECMO) in liver transplantation (LT) are scarce. ECMO has been used preoperatively, intraoperatively, and postoperatively for a variety of indications at our center. This retrospective, single-center study of ECMO use peri-LT aimed to describe predictors for successful outcome in this highly select cohort of patients. Demographics, support method
-
An unexpected biliary complication in a patient with remote liver transplant. Am. J. Transplant. (IF 8.9) Pub Date : 2024-09-01 Farah Ladak,Anand Ghanekar
-
World Health Assembly resolution: A global path forward in transplantation. Am. J. Transplant. (IF 8.9) Pub Date : 2024-09-01 Lara C Pullen
-
Increasing Azole-resistant environmental Aspergillus fumigatus in Denmark. Am. J. Transplant. (IF 8.9) Pub Date : 2024-09-01 Marcus R Pereira
-
Exploring microvascular inflammation and the spectrum of antibody-mediated rejection Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-30 Lynn D. Cornell, Ilkka Helanterä
-
Transcript analysis of uterus transplant cervical biopsies using the Banff Human Organ Transplant panel Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-30 Verena Broecker, Frederic Toulza, Mats Brännström, Angela Ernst, Candice Roufosse, Marie Carbonnel, Zeinab Alkattan, Johan Mölne
Uterus transplantation is being more widely implemented in clinical practice. Monitoring of rejection is routinely done for cervical biopsies and is dependent on histopathological assessment, as rejections are clinically silent and nonhistological biomarkers are missing. Until this gap is filled, it is important to corroborate the histopathological diagnosis of rejection through independent methods
-
A scoping review of the legal and ethical challenges with the use of normothermic regional perfusion in controlled donation after circulatory determination of death from 2005 to 2023 Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-30 Briget da Graca, Matthew Snoddy, Conner Fischbach, Sudha Ramakrishnan, Macey L. Levan, Brendan Parent, Giuliano Testa, Anji Wall
Use of normothermic regional perfusion (NRP) to enable organ reconditioning and assessment in donation after circulatory determination of death is controversial. We conducted a scoping review of peer-reviewed articles, news media, legal literature, and professional society position statements addressing ethical and/or legal issues in use of NRP in controlled donation after circulatory determination
-
Selecting weight loss strategies for kidney transplant candidacy: Weighty decisions Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-29 Babak J. Orandi
-
Phage-display immunoprecipitation for precision mapping the autoreactome Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-29 Priyanka Rashmi, Charles G. Rickert, James M. Gardner
-
Crossing national borders for transplantation: A focused evaluation of deceased donor lung exports from the United States Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-28 Rocio Lopez, Sumit Mohan, S. Ali Husain, Miko Yu, Susana Arrigain, Deena Brosi, Jordan R.H. Hoffman, Kenneth R. McCurry, Bruce Kaplan, Elizabeth A. Pomfret, Jesse D. Schold
Organ transplantation is a life-saving treatment for end-stage organ failure patients, but the United States (US) faces a shortage of available organs. US policies incentivize identifying recipients for all recovered organs. Technological advancements have extended donor organ viability, creating new opportunities for long-distance transport and international sharing. We aimed to assess organ exports
-
Transplantation pushes into the world of elite sports Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-28 Lara C. Pullen
-
Ischemia-reperfusion responses in human lung transplants at the single-cell resolution Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-26 Aaron Wong, Allen Duong, Gavin Wilson, Jonathan Yeung, Sonya MacParland, Hong Han, Marcelo Cypel, Shaf Keshavjee, Mingyao Liu
Ischemia-reperfusion is an unavoidable step of organ transplantation. Development of therapeutics for lung injury during transplantation has proved challenging; understanding lung injury from human data at the single-cell resolution is required to accelerate the development of therapeutics. Donor lung biopsies from 6 human lung transplant cases were collected at the end of cold preservation and 2-hour
-
Regarding the novel scoring system to predict short-term mortality after living donor liver transplantation for acute liver failure Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-23 Li Xiao
-
Artificial intelligence-driven automated lung sizing from chest radiographs Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-23 Mostafa K. Ismail, Tetsuro Araki, Warren B. Gefter, Yoshikazu Suzuki, Allie Raevsky, Aya Saleh, Sophia Yusuf, Abigail Marquis, Alyster Alcudia, Ian Duncan, Douglas E. Schaubel, Edward Cantu, Rahim Rizi
Lung size measurements play an important role in transplantation, as optimal donor-recipient size matching is necessary to ensure the best possible outcome. Although several strategies for size matching are currently used, all have limitations, and none has proven superior. In this pilot study, we leveraged deep learning and computer vision to develop an automated system for generating standardized
-
Declining mortality in the United States—Provisional data, 2023 Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-23 Marcus R. Pereira
-
Contemporary prevalence and practice patterns of out-of-sequence kidney allocation Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-23 Luckmini N. Liyanage, Daniyar Akizhanov, Suhani S. Patel, Dorry L. Segev, Allan B. Massie, Darren E. Stewart, Sommer E. Gentry
Since 2021, the Organ Procurement and Transplantation Network has reported a nearly 10-fold rise in out-of-sequence (OOS) kidney allocation, generating concern and halting development of continuous distribution policies. We report contemporary (2022-2023) practice patterns in OOS allocation using Organ Procurement and Transplantation Network data. We examined in sequence vs OOS donors with multivariable
-
Cure models, survival probabilities, and solid organ transplantation for patients with colorectal cancer. Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-23 Eric A Engels,Soutrik Mandal,Douglas A Corley,Christopher D Blosser,Allyson Hart,Charles F Lynch,Baozhen Qiao,Karen S Pawlish,Gregory Haber,Kelly J Yu,Ruth M Pfeiffer
A previous cancer diagnosis can preclude patients from consideration for solid organ transplantation. Statistical models may improve candidate selection. We fitted statistical cure models and estimated five-year cancer-specific survival (5yCSS) for colorectal cancer patients in the United States using registry data. The median cure probability at cancer diagnosis for patients in the general population
-
Benefits of liver transplant in critically ill patients with acute-on-chronic liver failure: Implementation of an urgent living-donor program Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-21 Hye-Mee Kwon, Jae Hwan Kim, Sung-Hoon Kim, In-Gu Jun, Jun-Gol Song, Deok-Bog Moon, Gyu-Sam Hwang
We evaluated the liver transplantation (LT) criteria in acute-on-chronic liver failure (ACLF), incorporating an urgent living-donor LT (LDLT) program. Critically ill patients with a Chronic Liver Failure Consortium (CLIF-C) ACLF score (CLIF-C_ACLF_score) ≥65, previously considered unsuitable for LT, were included to explore the excess mortality threshold of the CLIF-C_ACLF_score (CLIF-C_ACLF_score_threshold)
-
Temporal evolution of living donor liver transplantation survival—A United Network for Organ Sharing registry study Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-18 Christian T.J. Magyar, Zhihao Li, Laia Aceituno, Marco P.A.W. Claasen, Tommy Ivanics, Woo Jin Choi, Luckshi Rajendran, Blayne A. Sayed, Roxana Bucur, Nadia Rukavina, Nazia Selzner, Anand Ghanekar, Mark Cattral, Gonzalo Sapisochin
Living donor liver transplantation (LDLT) is a curative treatment for various liver diseases, reducing waitlist times and associated mortality. We aimed to assess the overall survival (OS), identify predictors for mortality, and analyze differences in risk factors over time. Adult patients undergoing LDLT were selected from the United Network for Organ Sharing database from inception (1987) to 2023
-
Moral injury: An unspoken burden of transplant surgery Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-17 Al-Faraaz Kassam, David A. Axelrod, Sunil K. Geevarghese
Moral injury in health care is characterized as the lasting psychological, biological, and social impact on providers that occurs following an adverse patient outcome. Moral injury can contribute to second victim syndrome and lasting psychological harm. Although many surgeons face moral injury due to patient acuity and the potential for intraoperative or postoperative complications, the transplant
-
Sex disparities in accessing liver transplantation: Biased renal function assessment is the main culprit Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-14 Manuel Luis Rodríguez-Perálvarez, Avik Majumdar, Emmanuel Tsochatzis
-
Corrigendum to ‘Criteria for prediabetes and posttransplant diabetes mellitus after kidney transplantation: A 2-year diagnostic accuracy study of participants from a randomized controlled trial’ [American Journal of Transplantation 22 (2022)2880-2891] Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-14 Amelie Kurnikowski, Espen Nordheim, Elisabeth Schwaiger, Simon Krenn, Jürgen Harreiter, Alexandra Kautzky-Willer, Michael Leutner, Johannes Werzowa, Andrea Tura, Klemens Budde, Kathrin Eller, Julio Pascual, Michael Krebs, Trond Geir Jenssen, Manfred Hecking
-
Disparities in liver transplantation: One size may not fit all Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-13 Allison J. Kwong, Alina M. Allen, Julie Heimbach
-
Trained immunity suppression determines kidney allograft survival Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-13 Inge Jonkman, Maaike M.E. Jacobs, Yutaka Negishi, Cansu Yanginlar, Joost H.A. Martens, Marijke Baltissen, Michiel Vermeulen, Martijn W.F. van den Hoogen, Marije Baas, Johan van der Vlag, Zahi A. Fayad, Abraham J.P. Teunissen, Joren C. Madsen, Jordi Ochando, Leo A.B. Joosten, Mihai G. Netea, Willem J.M. Mulder, Musa M. Mhlanga, Luuk B. Hilbrands, Nils Rother, Raphaël Duivenvoorden
The innate immune system plays an essential role in regulating the immune responses to kidney transplantation, but the mechanisms through which innate immune cells influence long-term graft survival are unclear. The current study highlights the vital role of trained immunity in kidney allograft survival. Trained immunity describes the epigenetic and metabolic changes that innate immune cells undergo
-
Deficiency in the mitophagy mediator Parkin accelerates murine skin allograft rejection Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-12 Kathleen M. Wragg, Matthew J. Worley, Jane C. Deng, Morgan Salmon, Daniel R. Goldstein
Alterations in mitochondrial function and associated quality control programs, including mitochondrial-specific autophagy, termed mitophagy, are gaining increasing recognition in the context of disease. However, the role of mitophagy in organ transplant rejection remains poorly understood. Using mice deficient in Parkin, a ubiquitin ligase that tags damaged or dysfunctional mitochondria for autophagic
-
Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidates Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-10 Alba Torija, Marie Matignon, Flavio Vincenti, Franc Casanova-Ferrer, Caroline Pilon, Anat R. Tambur, Laura Donadeu, Elena Crespo, Delphine Kervella, Maria Meneghini, Irina B. Torres, Florianne Hafkamp, Anna Martinez-Lacalle, Claudia Carrera, José Zúñiga, Amarpali Brar, Josep Cruzado, A. Osama Gaber, Helen Lee, Robert A. Montgomery, Mark Stegall, Maryvonnick Carmagnat, Cédric Usureau, Francesc Moreso
High human leukocyte antigen (HLA) sensitization limits access to compatible transplantation. New CD38-targeting agents have been shown to reduce anti-HLA antibodies, although with important interpatient variability. Thus, pretreatment identification of responder and nonresponder (NR) patients is needed for treatment decision-making. We analyzed 26 highly sensitized (HS) patients from 2 desensitization
-
Donor-derived membranous nephropathy in the allograft kidney: A rare but probably underestimated complication Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-09 Rachel A. Nuccitelli, Hilda E. Fernandez, S. Ali Husain, Satoru Kudose, Ibrahim Batal, Miroslav Sekulic
Transmitted donor-derived glomerular diseases in the allograft kidney are rare, especially when encountered in an allograft from a living donor. To date, only individual reports of donor-derived membranous nephropathy (MN) have been described. In this report, we present a case of MN discovered in a postreperfusion biopsy of a living-donor allograft. A follow-up biopsy 3 weeks later demonstrated persistent
-
Corrigendum to ‘A novel scoring system to predict short-term mortality after living donor liver transplantation for acute liver failure’ American Journal of Transplantation, Available online 29 April 2024, In Press, Corrected Proof. Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-08 Keita Shimata, Young-In Yoon, Taizo Hibi, Jun Morinaga, Anila Kutty Narayanan, Takeo Toshima, Takashi Ito, Nobuhisa Akamatsu, Yoshihito Kotera, Suk Kyun Hong, Yasushi Hasegawa, Yuzo Umeda, Mettu Srinivas Reddy, Aldwin De Leon Ong, Saraswathy Sivaprasadan, Joy Varghese, Yasuhiko Sugawara, Chao-Long Chen, Nobuaki Nakayama, Satoshi Mochida, Atsushi Tanaka, Kyung-Suk Suh, Toru Ikegami, Kwang-Woong Lee
-
Hybrid immunity protection against SARS-CoV-2 and severe COVID-19 in kidney transplantation: A retrospective, comparative cohort study Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-07 Alexandre Favà, Carlos Couceiro, Laura Calatayud, Yolanda Hernandez-Hermida, Edoardo Melilli, Nuria Montero, Anna Manonelles, Ana Coloma, Sergi Codina, Nuria Lloberas, Laia Oliveras, Luis Arturo Lino, Claudia Galofré, Nuria Sabé, Francisco Gomez-Preciado, Diego Sandoval, Daniel Pizarro, Maria Angeles Domínguez, Josep Maria Cruzado
Hybrid immunity, resulting from a combination of SARS-CoV-2 infection and vaccination, offers robust protection against COVID-19 in the general population. However, its impact on immunocompromised patients remains unexplored. We investigated the effect of hybrid immunity against the Omicron variant in a population of kidney transplant recipients receiving the fourth dose mRNA monovalent vaccination
-
Murine kidney transplant outcome is best measured by transdermal glomerular filtration rate Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-07 Collin Z. Jordan, Yanting Chen, Irma Husain, Miriam Dilts, Olivia K. Fay, Jamie Privratsky, Xunrong Luo, Matthew Tunbridge
Mouse kidney transplantation provides a powerful preclinical model for the study of kidney transplant alloimmunity. However, accurate measurement of graft function is difficult because of the inaccuracy of traditional surrogate markers serum creatinine and urea. We report the use of transdermal glomerular filtration rate measurement under the experimental conditions of unilateral nephrectomy and allogeneic
-
Subthreshold rejection activity in many kidney transplants currently classified as having no rejection Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-06 Philip F. Halloran, Katelynn S. Madill-Thomsen, Georg Böhmig, Jonathan Bromberg, Klemens Budde, Meagan Barner, Martina Mackova, Jessica Chang, Gunilla Einecke, Farsad Eskandary, Gaurav Gupta, Marek Myślak, Ondrej Viklicky, Enver Akalin, Tarek Alhamad, Sanjiv Anand, Miha Arnol, Rajendra Baliga, Mirosław Banasik, Adam Bingaman, Christopher D. Blosser, Daniel Brennan, Andrzej Chamienia, Kevin Chow, Michał
Most kidney transplant patients who undergo biopsies are classified as having no rejection based on consensus thresholds. However, we hypothesized that because these patients have normal adaptive immune systems, T cell–mediated rejection (TCMR) and antibody-mediated rejection (ABMR) may exist as subthreshold activity in some transplants currently classified as no rejection. To examine this question
-
Living donor liver transplant in Colombia, with a proposal to reduce geographic disparity in Latin America Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-06 Andres Gomez-Aldana, Rosselli Diego
-
A competing risks model to estimate the risk of graft failure and patient death after kidney transplantation using continuous donor-recipient age combinations Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-05 Maarten Coemans, Thuong Hien Tran, Bernd Döhler, Allan B. Massie, Geert Verbeke, Dorry L. Segev, Sommer E. Gentry, Maarten Naesens
Graft failure and recipient death with functioning graft are important competing outcomes after kidney transplantation. Risk prediction models typically censor for the competing outcome thereby overestimating the cumulative incidence. The magnitude of this overestimation is not well described in real-world transplant data. This retrospective cohort study analyzed data from the European Collaborative
-
Avian Influenza: Protecting Our Canaries Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-05 Lara C. Pullen PhD
-
CDC guidance on new pentavalent meningococcal vaccine Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-05 Marcus R. Pereira
-
Real-time thermoconductive monitoring for early detection of kidney transplant rejection Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-05 Alexander R. Gupta, Charles G. Rickert, James M. Gardner
-
Donor nephrolithiasis–induced acute kidney injury in a kidney transplant recipient Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-05 Marlene Hernandez, Pranit N. Chotai, Alejandro Diez, Amer Rajab
-
Murine orthotopic lung transplant models: A comprehensive overview of genetic mismatch degrees and histopathological insights into chronic lung allograft dysfunction Am. J. Transplant. (IF 8.9) Pub Date : 2024-08-02 Axelle Coppens, Stijn E. Verleden, Erik Claes, Hanne Voet, Geert M. Verleden, Therese S. Lapperre, Ali Ö. Yildirim, Wolfgang Jungraithmayr, Yoshito Yamada, Dieter J.E. Peeters, Jeroen M.H. Hendriks
Currently, lung transplantation outcome remains inferior compared to other solid organ transplantations. A major cause for limited survival after lung transplantation is chronic lung allograft dysfunction. Numerous animal models have been developed to investigate chronic lung allograft dysfunction to discover adequate treatments. The murine orthotopic lung transplant model has been further optimized
-
Pancreas transplantation as rescue therapy in a patient with type 1 diabetes and concurrent subcutaneous insulin resistance Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-31 Florian Fueermann, Katharina Heller, Marianne Pavel, Larissa Herbst, Robert Grützmann, Mario Schiffer
Patients with type 1 diabetes and concurrent subcutaneous insulin resistance present unique diagnostic and therapeutic challenges for clinicians. The standard therapeutic approach is the administration of intravenous insulin. Pancreatic transplantation should be considered at an appropriate time, particularly in the event of life-threatening ketoacidosis, hyperglycemia, hypoglycemia, catheter-associated
-
Efficacy and safety of COVID-19 vaccination in solid organ transplant recipients: A systematic review and network meta-analysis Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-31 Daniel G. Rayner, Jairo T. Nunes, David Gou, Alexandro W.L. Chu, Si-Cheng Dai, Aleesha Sheikh, Dorisa Meng, Ani Orchanian-Cheff, Shelly Oss, Coleman Rotstein, Natasha Aleksova, Farid Foroutan
The impact of COVID-19 vaccination on clinical outcomes in solid organ transplant (SOT) recipients remains unclear. This systematic review and network meta-analysis sought to assess the efficacy and safety of COVID-19 vaccination in SOT recipients. We searched 6 databases from inception to March 1, 2024 for randomized controlled trials (RCTs) and observational studies evaluating different COVID-19
-
Liver transplantation for acute liver failure and acute-on-chronic liver failure Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-31 Anand V. Kulkarni, Thierry Gustot, K. Rajender Reddy
Acute liver failure (ALF) and acute-on-chronic liver (ACLF) are distinct phenotypes of liver failure and, thus, need to be compared and contrasted for appropriate management. There has been a significant improvement in the outcomes of these patients undergoing liver transplantation (LT). Survival post-LT for ALF and ACLF ranges between 90% and 95% and 80% and 90% at 1 year, futility criteria have been
-
Impact of short-term vegan versus ketogenic diets on human immunity and microbiome Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-31 Nolan K. Horner, Eva M. Gillis-Buck MD MPhil, James M. Gardner MD PhD
-
The relationship of microvascular inflammation with antibody-mediated rejection in kidney transplantation Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-30 Brian J. Nankivell, Anne Taverniti, Seethalakshmi Viswanathan, John Ronquillo, Robert Carroll, Ankit Sharma
Microvascular inflammation (MVI) is a key diagnostic feature of antibody-mediated rejection (AMR); however, recipients without donor-specific antibodies (DSA) defy etiologic classification using C4d staining of peritubular capillaries (C4d) and conventional DSA assignment. We evaluated MVI ≥ 2 (Banff g + ptc ≥ 2) using Banff 2019 AMR (independent of MVI ≥ 2 but including C4d) with unconventional endothelial
-
Racial and ethnic disparities in transplantation: Swimming even further upstream to achieve equity Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-30 Joel T. Adler, Rachel E. Patzer
-
Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-30 Chethan M. Puttarajappa, Kenneth J. Smith, Bestoun H. Ahmed, Karla Bernardi, Linda-Marie Lavenburg, William Hoffman, Michele Molinari
Novel antiobesity medications, particularly glucagon-like peptide-1 receptor agonists (GLP-1RAs), have expanded weight loss (WL) options for kidney transplantation (KT) candidates with obesity beyond lifestyle modifications and bariatric surgery. However, varying effectiveness, risk profiles, and costs make strategy choices challenging. To aid decision-making, we used a Markov model to examine the
-
Clinical and molecular spectrum of v-lesion Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-29 Anna Buxeda, Marta Crespo, Betty Chamoun, Javier Gimeno, Irina B. Torres, Dolores Redondo-Pachón, Marta Riera, Carla Burballa, Julio Pascual, Michael Mengel, Benjamin A. Adam, María José Pérez-Sáez
Isolated v-lesion presents diagnostic stratification and clinical challenges. We characterized allograft outcomes for this entity based on posttransplant time (early: ≤1 month vs late: >1 month) and compared its molecular phenotype with other v+ rejection forms. Using the NanoString B-HOT panel, we analyzed 92 archival formalin-fixed paraffin-embedded tissue kidney biopsies from 3 centers: isolated
-
The transcriptional repressor B cell lymphoma 6 regulates CXCR3 chemokine and human leukocyte antigen II expression in endothelial cells Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-27 Adriana Franco Acevedo, Julia J. Mack, Nicole M. Valenzuela
Interferon gamma (IFN-γ) induces an endothelial proimmunogenic phenotype through the JAK/STAT1 pathway, which can shape the activation of alloreactive leukocytes in transplant rejection. In immune cells, the DNA-binding protein B cell lymphoma 6 (BCL6) controls the transcription of inflammatory genes. This study tested if BCL6 modulates IFN-γ-induced gene expression in endothelial cells. In vitro,
-
Corrigendum to Racial disparities across multiple stages of the deceased organ donation process Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-25 Raymond C. Givens
-
Long-term ex situ normothermic machine perfusion allows regeneration of human livers with severe bile duct injury Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-24 Mark Ly, Ngee-Soon Lau, Claude Dennis, Jinbiao Chen, Charles Risbey, Sarah Tan, Renfen Chen, Chuanmin Wang, Mark D. Gorrell, Catriona McKenzie, James G. Kench, Ken Liu, Geoffrey W. McCaughan, Michael Crawford, Carlo Pulitano
Bile duct regeneration is hypothesized to prevent biliary strictures, a leading cause of morbidity after liver transplantation. Assessing the capacity for biliary regeneration may identify grafts as suitable for transplantation that are currently declined, but this has been unfeasible until now. This study used long-term ex situ normothermic machine perfusion (LT-NMP) to assess biliary regeneration
-
Public attitudes to xenotransplantation: A national survey in the United States Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-23 Luz A. Padilla, Daniel J. Hurst, Amanda Zink, Brendan Parent, Laura L. Kimberly
Xenotransplantation (XTx) presents a potential clinical alternative to the shortage of human organs for transplantation. Before clinical trials occur in the United States, public assessments are crucial to understand potential barriers to acceptance. The purpose of this study was to explore barriers and identify characteristics associated with attitudes toward XTx. A survey assessing demographic characteristics
-
Continuous glucose monitoring for the prediction of posttransplant diabetes mellitus and impaired glucose tolerance on day 90 after kidney transplantation—A prospective proof-of-concept study Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-22 Georgios Eleftheriadis, Marcel G. Naik, Bilgin Osmanodja, Lutz Liefeldt, Mira Choi, Fabian Halleck, Eva Schrezenmeier, Kai-Uwe Eckardt, Mareen Pigorsch, Andrea Tura, Amelie Kurnikowski, Manfred Hecking, Klemens Budde
Posttransplant diabetes mellitus (PTDM) and prediabetes represent serious complications after kidney transplantation and are associated with increased cardiovascular morbidity and mortality. We assessed the predictive performance of continuous glucose monitoring (CGM) compared with plasma glucose and hemoglobin A1c in 46 kidney transplant recipients (KTRs) without known preexisting diabetes mellitus
-
From prognostication to therapeutics: Four key questions to accelerate the development of therapeutics for patients with acute-on-chronic liver failure Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-22 Jennifer C. Lai, S.K. Sarin, Pere Gines
Acute-on-chronic liver failure (ACLF) has come a long way as a clinical concept within the hepatology and liver transplant communities. Though the term was proposed in 1995, the first recognition of the entity along with a consensus definition emerged in 2009. Subsequently, the entity has sparked great interest, inspired several consensus conferences, and inspired national societies to form professional
-
Long-term persistence of seroprotection against measles following measles-mumps-rubella vaccination administered before and after pediatric liver transplantation Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-18 Laure F. Pittet, Renato Gualtieri, Charlotte M. Verolet, Arnaud G. L’Huillier, Barbara E. Wildhaber, Valérie A. McLin, Klara M. Posfay-Barbe
Liver transplantation (LT) recipients are susceptible to infections, including measles. Concerns about the safety and efficacy of live-attenuated vaccines, such as the measles-mumps-rubella (MMR) vaccine, have led to hesitancy among providers in administering them to immunocompromised patients. This 9-year interventional study assessed seroprotection against measles following MMR vaccination in pediatric
-
Probable antibody-mediated rejection in kidney transplantation is a rare and challenging phenotype to define: Findings from a single-center study Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-18 Karolien Wellekens, Maarten Coemans, Jasper Callemeyn, Evert Cleenders, Tim Debyser, Steffi De Pelsmaeker, Marie-Paule Emonds, Priyanka Koshy, Dirk Kuypers, Angelica Pagliazzi, Candice Roufosse, Aleksandar Senev, Elisabet Van Loon, Thibaut Vaulet, Maarten Naesens
The Banff 2022 consensus introduced probable antibody-mediated rejection (AMR), characterized by mild AMR histologic features and human leukocyte antigen (HLA) donor-specific antibody (DSA) positivity. In a single-center observational cohort study of 1891 kidney transplant recipients transplanted between 2004 and 2021, 566 kidney biopsies were performed in 178 individual HLA-DSA–positive transplants
-
Rescue with obinutuzumab and daratumumab as combined B cell/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-17 Paolo Randone, Enrico Sanna, Caterina Dolla, Ester Gallo, Silvia Mingozzi, Rita Tarragoni, Maria Cristina Torazza, Anna Niarchos, Alberto Mella, Ana Maria Manzione, Antonella Barreca, Ilaria Deambrosis, Roberta Giraudi, Luigi Biancone
The recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation is associated with a high graft loss rate with standard treatments based on plasmapheresis with/without rituximab. We present 2 consecutive cases of nongenetic early severe recurrent FSGS refractory to rituximab and anti–interleukin 1 treatment and with a partial response to plasmapheresis. Case 1 was a
-
Development of an improved Scientific Registry of Transplant Recipients deceased donor heart yield model using donor critical care data from the Donor Management Goal Registry cohort Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-16 Elizabeth A. Swanson, Shaina Kian, Samantha Noreen, Gaya Shivega, Virginia McBride, Paul Lange, Mitchell B. Sally, Darren J. Malinoski
Organ procurement organizations (OPOs) face increasing regulatory scrutiny, and the performance of predictive models used to assess OPO performance is critical. We sought to determine whether adding deceased donor physiological and critical care data to the existing Scientific Registry of Transplant Recipients (SRTR) heart yield model would improve the model’s performance. Donor data and heart transplanted
-
Donor-derived Mycoplasma and Ureaplasma infections in lung transplant recipients: A prospective study of donor and recipient respiratory tract screening and recipient outcomes Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-16 Patrick C.K. Tam, Barbara D. Alexander, Mark J. Lee, Rochelle G. Hardie, John M. Reynolds, John C. Haney, Ken B. Waites, John R. Perfect, Arthur W. Baker
and species are urogenital mollicutes that can cause serious donor-derived infections in lung transplant recipients. Best practices for mollicute screening remain unknown. We conducted a single-center prospective study analyzing lung transplants performed from October 5, 2020, to September 25, 2021, whereby donor and recipient bronchoalveolar lavage (BAL) samples obtained at time of transplant underwent
-
Organ Procurement Organization-level variation in A1/A2 subtyping of deceased donors Am. J. Transplant. (IF 8.9) Pub Date : 2024-07-15 Shivani S. Bisen, Laura B. Zeiser, Darren E. Stewart, Bonnie E. Lonze, Dorry L. Segev, Allan B. Massie